Patents by Inventor Yixian Zhang

Yixian Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anilino-pyrimidine analogs
    Patent number: 7799915
    Abstract: The present invention relates to compounds of formula I: wherein R1, R2, R3, R4, R5, and R6 are defined herein.
    Type: Grant
    Filed: October 13, 2005
    Date of Patent: September 21, 2010
    Assignee: Wyeth LLC
    Inventors: Fuk-Wah Sum, Dennis William Powell, Yixian Zhang, Lijing Chen, Scott Lee Kincaid, Lee Dalton Jennings, Yongbo Hu, Adam Matthew Gilbert, Matthew Gregory Bursavich
  • Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer
    Publication number: 20090062133
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. FKBP markers are provided, wherein changes in the levels of expression of one or more of the FKBP markers is correlated with the presence of prostate cancer.
    Type: Application
    Filed: July 3, 2008
    Publication date: March 5, 2009
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Expression analysis of FKBP54 in assessing prostate cancer therapy
    Patent number: 7402388
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. FKBP markers are provided, wherein changes in the levels of expression of one or more of the FKBP markers is correlated with the presence of prostate cancer.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: July 22, 2008
    Assignee: Wyeth
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
    Patent number: 7037652
    Abstract: The invention relates to methods for detecting, characterizing, preventing, and treating prostate cancer. KIAA markers are provided, wherein changes in the levels of expression of one or more of the KIAA markers is correlated with the presence of prostate cancer.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: May 2, 2006
    Assignee: Wyeth
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Anilino-pyrimidine analogs
    Publication number: 20060079543
    Abstract: The present invention relates to compounds of formula I: wherein R1, R2, R3, R4, R5, and R6 are defined herein.
    Type: Application
    Filed: October 13, 2005
    Publication date: April 13, 2006
    Applicant: Wyeth
    Inventors: Fuk-Wah Sum, Dennis Powell, Yixian Zhang, Lijing Chen, Scott Kincaid, Lee Jennings, Yongbo Hu, Adam Gilbert, Matthew Bursavich
  • Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer
    Publication number: 20050069946
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. FKBP markers are provided, wherein changes in the levels of expression of one or more of the FKBP markers is correlated with the presence of prostate cancer.
    Type: Application
    Filed: November 23, 2004
    Publication date: March 31, 2005
    Inventors: Kimberly Gillis, Yixian Zhang
  • Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
    Patent number: 6821731
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. FKBP markers are provided, wherein changes in the levels of expression of one or more of the FKBP markers is correlated with the presence of prostate cancer.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: November 23, 2004
    Assignee: Wyeth
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Method of treating estrogen receptor positive carcinoma
    Patent number: 6511986
    Abstract: This invention provides a method of treating or inhibiting an estrogen receptor positive carcinoma in a mammal in need thereof, which comprises providing said mammal with an effective amount of a combination of a rapamycin and an antiestrogen.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: January 28, 2003
    Assignee: Wyeth
    Inventors: Yixian Zhang, Tammy M. Sadler, Philip Frost, Lee Martin Greenberger
  • Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
    Publication number: 20020182614
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. ID markers are provided, wherein changes in the levels of expression of one or more of the ID markers is correlated with the presence of prostate cancer.
    Type: Application
    Filed: November 28, 2001
    Publication date: December 5, 2002
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
    Publication number: 20020168650
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. FKBP markers are provided, wherein changes in the levels of expression of one or more of the FKBP markers is correlated with the presence of prostate cancer.
    Type: Application
    Filed: November 28, 2001
    Publication date: November 14, 2002
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
    Publication number: 20020142327
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. SWI/SNF-related matrix-associated actin-dependent regulator of chromatin (SMARC) markers are provided, wherein changes in the levels of expression of one or more of the SMARC markers is correlated with the presence of prostate cancer.
    Type: Application
    Filed: November 28, 2001
    Publication date: October 3, 2002
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
    Publication number: 20020115090
    Abstract: The invention relates to methods for detecting, characterizing, preventing, and treating prostate cancer. KIAA markers are provided, wherein changes in the levels of expression of one or more of the KIAA markers is correlated with the presence of prostate cancer.
    Type: Application
    Filed: November 28, 2001
    Publication date: August 22, 2002
    Inventors: Kimberly A. Gillis, Yixian Zhang
  • Method of treating estrogen receptor positive carcinoma
    Publication number: 20020045638
    Abstract: This invention provides a method of treating or inhibiting an estrogen receptor positive carcinoma in a mammal in need thereof, which comprises providing said mammal with an effective amount of a combination of a rapamycin and an antiestrogen.
    Type: Application
    Filed: August 6, 2001
    Publication date: April 18, 2002
    Inventors: Yixian Zhang, Tammy M. Sadler, Philip Frost, Lee Martin Greenberger